These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9466070)

  • 1. Mastoid obliteration with hydroxyapatite--the value of high resolution CT scanning in detecting recurrent cholesteatoma.
    Yung MM; Karia KR
    Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):553-7. PubMed ID: 9466070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of hydroxyapatite granules in mastoid obliteration.
    Yung MW
    Clin Otolaryngol Allied Sci; 1996 Dec; 21(6):480-4. PubMed ID: 9118565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.
    Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E
    J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mastoid obliteration techniques in cholesteatoma.
    Yung M; Bennett A
    Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):455-60. PubMed ID: 23872728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration.
    Yanagihara N; Komori M; Hinohira Y
    Otol Neurotol; 2009 Sep; 30(6):766-70. PubMed ID: 19704361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance.
    Bernardeschi D; Law-Ye B; Bielle F; Hochet B; Sterkers O; Dormont D; Pyatigorskaya N
    Eur Radiol; 2019 Oct; 29(10):5617-5626. PubMed ID: 30888487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tympanoplasty with mastoid obliteration using hydroxyapatite granules for aural cholesteatoma--a clinical and experimental study].
    Takahashi S
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Jun; 94(6):833-42. PubMed ID: 1653315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of high-resolution computed tomography and magnetic resonance imaging in the detection of residual cholesteatomas in primary bony obliterated mastoids.
    De Foer B; Vercruysse JP; Pouillon M; Somers T; Casselman JW; Offeciers E
    Am J Otolaryngol; 2007; 28(4):230-4. PubMed ID: 17606036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.
    Lindeboom JJ; van Kempen PMW; Buwalda J; Westerlaken BO; van Zuijlen DA; Bom SJH; van der Beek FB
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1703-1711. PubMed ID: 36173443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the value of the preoperative computed tomography scans prior to otoendoscopic 'second look' in intact canal wall mastoid surgery.
    Tierney PA; Pracy P; Blaney SP; Bowdler DA
    Clin Otolaryngol Allied Sci; 1999 Aug; 24(4):274-6. PubMed ID: 10472459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative diffusion weighted MRI and preoperative CT scan fusion for residual cholesteatoma localization.
    Alzahrani M; Alhazmi R; Bélair M; Saliba I
    Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():259-263. PubMed ID: 27729145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI, not CT, to rule out recurrent cholesteatoma and avoid unnecessary second-look mastoidectomy.
    Migirov L; Tal S; Eyal A; Kronenberg J
    Isr Med Assoc J; 2009 Mar; 11(3):144-6. PubMed ID: 19544702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary experience with beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy.
    Minoda R; Hayashida M; Masuda M; Yumoto E
    Otol Neurotol; 2007 Dec; 28(8):1018-21. PubMed ID: 17898672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesteatoma: rare, but can have serious consequences].
    Timmer ML; Borggreven PA; van de Langenberg R; Quak JJ; Colnot DR
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma.
    Hellingman CA; Geerse S; de Wolf MJF; Ebbens FA; van Spronsen E
    Laryngoscope; 2019 Apr; 129(4):981-985. PubMed ID: 30408197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastoid cavity obliteration: our experience.
    Deshmukh S; Sharma A; Dabholkar J
    Otolaryngol Pol; 2012; 66(6):379-81. PubMed ID: 23200556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using high resolution computed tomography to evaluate middle ear cleft aeration of postoperative cholesteatoma ears.
    Lan MY; Lien CF; Liao WH
    J Chin Med Assoc; 2003 Apr; 66(4):217-23. PubMed ID: 12854873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic approach to interpretation of computed tomography scans prior to surgery of middle ear cholesteatoma.
    Watts S; Flood LM; Clifford K
    J Laryngol Otol; 2000 Apr; 114(4):248-53. PubMed ID: 10845037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital cholesteatoma of mastoid origin.
    Lee JH; Hong SJ; Park CH; Jung SH
    J Laryngol Otol; 2007 Nov; 121(11):e20. PubMed ID: 17931451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.